In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Invitrogen buys Applied Biosystems for $6.3bn

Executive Summary

Invitrogen is buying Applera's Applied Biosystems Group for $6.3bn. Holders of Applera-Applied Biosystems common stock will receive $38 (a 12% premium and contingent upon Invitrogen's share price when the transaction closes) in Invitrogen stock and cash for each share they own. (Invitrogen estimates a split between cash and stock of 45% and 55%, respectively).
Deal Industry
  • Pharmaceuticals
  • Research, Analytical Equipment & Supplies
  • Research, Analytical Equipment & Supplies
    • PCR & Amplification Tools
  • Biotechnology
    • Drug Discovery Tools
      • Genomics-Proteomics
Deal Status
  • Final
Deal Type
  • Acquisition
    • Full Acquisition
    • Includes Contract
    • Intra-Biotech Deal
    • Payment Includes Cash
    • Payment Includes Stock
    • Reverse Acquisition

Related Companies